✦ LIBER ✦

Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting

✍ Scribed by Mandorfer, Mattias; Payer, Berit A.; Niederecker, Alexander; Lang, Gerold; Aichelburg, Maximilian C.; Strassl, Robert; Boesecke, Christoph; Rieger, Armin; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas

Book ID: 125853009
Publisher: Mary Ann Liebert
Year: 2014
Tongue: English
Weight: 229 KB
Volume: 28
Category: Article
ISSN: 1087-2914
DOI: 10.1089/apc.2013.0359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Telaprevir or boceprevir triple therapy

Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis

✍ Saxena, V.; Manos, M. M.; Yee, H. S.; Catalli, L.; Wayne, E.; Murphy, R. C.; Shv 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

1216 ACCESS TO HCV TRIPLE THERAPY WITH T

1216 ACCESS TO HCV TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR WITH PEGINTERFERON RIBAVIRIN IN REAL LIFE SETTING IN HIV–HCV CO-INFECTED PATIENTS – ANRS CO13 Hepavih COHORT

✍ Poizot-Martin, I.; Merchadou, L.; Carrieri, P.; Miailhes, P.; Domingues, S.; Dab 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Boceprevir (BOC) and Telaprevir (TPV) th

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment

✍ Chantry, AS; Tching-Sin, M; Dhiver, C; Allegre, T; Ruiz, JM; Assi, A; Botta-Frid 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 90 KB

A randomized, controlled trial of triple

A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients

✍ Massimo Puoti; Barbara Zanini; Gian Paolo Quinzan; Laura Ravasio; Giuseppe Paran 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB

P1146 VIROLOGICAL RESPONSE AND TOLERANCE

P1146 VIROLOGICAL RESPONSE AND TOLERANCE TO BOCEPREVIR OR TELAPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN TRIPLE THERAPY IN HIV–HCV CO-INFECTED PATIENTS: REAL-LIFE FINDINGS FROM THE PAN STUDY

✍ Baumgarten, A.; Holm, S.; Lutz, T.; Schranz, D.; Mauss, S.; Hillenbrand, H.; Mol 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB